FFO
MGNX icon

Fortitude Family Office’s MacroGenics MGNX Stock Holding History

Fortitude Family Office’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27K Hold
276
– – ﹤0.01% 1662
2026
Q1 		$798 Buy
+276
New +$589 ﹤0.01% 1569
2024
Q3 		– Sell
-455
Closed -$1.93K – 1247
2024
Q2 		$1.93K Sell
455
-279
-38% -$2.72K ﹤0.01% 813
2024
Q1 		$10.8K Hold
734
– – 0.01% 380
2023
Q4 		$7.06K Buy
+734
New +$5.07K 0.01% 500

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fortitude Family Office's MGNX Position: Q2 2026 in Review

Fortitude Family Office held its MacroGenics (MGNX) position steady in Q2 2026 at 276 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1662.

Fortitude Family Office first reported a position in MGNX in Q4 2023 and has held it in 5 quarters since. The position peaked at $10.8K in Q1 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Fortitude Family Office held 276 shares of MacroGenics worth $1.27K as of Q2 2026.
  • Fortitude Family Office left its MacroGenics share count unchanged in Q2 2026.
  • MacroGenics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1662 holding.
  • Fortitude Family Office first reported a position in MacroGenics in Q4 2023 and has held it in 5 quarters since.
  • Fortitude Family Office's MacroGenics position peaked at $10.8K in Q1 2024.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.